Bioluminescence assays and imaging methods have been widely adopted for drug discovery because of their simplicity, robustness, and low-cost. The inherently low background and lack of need for excitation light makes bioluminescence superior to fluorescence methods for many applications. Nevertheless, bioluminescence has yet to reach its full potential. We propose the following specific aims: 1) Expand the scope of bioluminescence imaging with synthetic luciferins; 2) Develop bright and functionally orthogonal luciferases suitable for in vivo imaging; and 3) Leverage ?portable reporters? for imaging in any animal. We will exploit the properties of synthetic luciferin analogs to enhance the imaging of invasive brain tumors, viral infection of the CNS, and circadian rhythms. We will develop fully orthogonal luciferin-luciferase pairs that can serve as internal controls and enable multiplexed imaging. Finally, we will overcome the restricted set of available luciferase-expressing animals by developing bioluminescent reporters that can be introduced into any animal of interest.

Public Health Relevance

The light emission from firefly luciferase is widely used as an optical reporter to help identify new therapeutic molecules. Increasingly, the glow of light from luciferase is being used to image disease progression in living organisms. The work we propose will greatly improve the sensitivity and applicability of luciferase for both the identification of new drug candidates and the low-cost imaging of living organisms.

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Research Project (R01)
Project #
2R01EB013270-05A1
Application #
9457283
Study Section
Synthetic and Biological Chemistry A Study Section (SBCA)
Program Officer
Atanasijevic, Tatjana
Project Start
2011-09-30
Project End
2021-06-30
Budget Start
2017-09-30
Budget End
2018-06-30
Support Year
5
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Biochemistry
Type
Schools of Medicine
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655
Miller, Stephen C; Mofford, David M; Adams Jr, Spencer T (2018) Lessons Learned from Luminous Luciferins and Latent Luciferases. ACS Chem Biol 13:1734-1740
Mofford, David M; Liebmann, Kate L; Sankaran, Ganapathy Subramanian et al. (2017) Luciferase Activity of Insect Fatty Acyl-CoA Synthetases with Synthetic Luciferins. ACS Chem Biol 12:2946-2951
Adams Jr, Spencer T; Mofford, David M; Reddy, G S Kiran Kumar et al. (2016) Firefly Luciferase Mutants Allow Substrate-Selective Bioluminescence Imaging in the Mouse Brain. Angew Chem Int Ed Engl 55:4943-6
Mofford, David M; Adams Jr, Spencer T; Reddy, G S Kiran Kumar et al. (2015) Luciferin Amides Enable in Vivo Bioluminescence Detection of Endogenous Fatty Acid Amide Hydrolase Activity. J Am Chem Soc 137:8684-7
Mofford, David M; Reddy, Gadarla Randheer; Miller, Stephen C (2014) Latent luciferase activity in the fruit fly revealed by a synthetic luciferin. Proc Natl Acad Sci U S A 111:4443-8
Adams Jr, Spencer T; Miller, Stephen C (2014) Beyond D-luciferin: expanding the scope of bioluminescence imaging in vivo. Curr Opin Chem Biol 21:112-20
Mofford, David M; Reddy, Gadarla Randheer; Miller, Stephen C (2014) Aminoluciferins extend firefly luciferase bioluminescence into the near-infrared and can be preferred substrates over D-luciferin. J Am Chem Soc 136:13277-82
Evans, Melanie S; Chaurette, Joanna P; Adams Jr, Spencer T et al. (2014) A synthetic luciferin improves bioluminescence imaging in live mice. Nat Methods 11:393-5
Godinat, Aurélien; Park, Hyo Min; Miller, Stephen C et al. (2013) A biocompatible in vivo ligation reaction and its application for noninvasive bioluminescent imaging of protease activity in living mice. ACS Chem Biol 8:987-99
Harwood, Katryn R; Mofford, David M; Reddy, Gadarla R et al. (2011) Identification of mutant firefly luciferases that efficiently utilize aminoluciferins. Chem Biol 18:1649-57